Pfizer appoints new medical director in Mexico

  • The doctor, appointed as the new medical director of Pfizer in Mexico, is a graduate of the Autonomous University of Central America in Costa Rica.
  • The company doubled its profits globally during 2021, thanks in part to developing a vaccine against Covid-19.
  • In 2023, the pharmaceutical company plans to introduce new treatments for migraine, atopic dermatitis, amyloidosis cardiomyopathy, and various types of cancer.

The work of medical professionals is not limited to caring for patients in clinics. They may also hold other positions and even be responsible for very important areas in pharmaceutical companies. That’s how it goes Pfizer has announced the appointment of a new medical director for Mexico.

In this sense, this American-born company has established itself as one of the most important in the world. Its foundation dates back to 1849, although it is currently involved in the development and manufacture of medical care products and vaccines.

In fact, at the end of 2020, it made history because it was the first company to receive vaccine against Covid-19. Biological, developed jointly with BioNTek got a trade name comyrnates.

For their part, both this immunization and the treatment developed against this disease have caused The pharmaceutical company will double its profits in 2021, growing from $41.9 billion to $81 billion.

Pfizer appoints new medical director in Mexico

In order to continue its efforts to provide people with the most innovative treatments on the market to improve their quality of life, the company has released an important announcement. Now he Dr. Daniel Bustos will take up the position of medical director in Mexico.

With 13 years of experience in the company, Dr. Bustos comes to the country after working as a medical director in Central America and the Caribbean. In his previous work, he led the overall medical strategy in six categories: internal medicine; hospitals/antimicrobial facilities; oncology; vaccine; rare diseases and immunology and inflammation.

What is your academic and professional background?

As part of his training, he is a surgeon in Autonomous University of Central America (UACA) in Costa Rica. He also received a Cardiovascular Clinical Fellowship from the University of California, Los Angeles (UCLA) and completed his PhD in Regulatory Sciences from the University of Southern California (USC).

He later graduated from the Senior Management Program at the Central American Institute of Business Administration (INCAE). He also received a Master’s Degree in Global Cardiovascular Risk Prevention from Alcalá de Henares University in Madrid and completed the Professional Certificate Program in Medicine and Drug Development from King’s College London, UK.

The arrival of Daniel Bustos in Mexico follows the relocation of Dr. Jessica Moreno, who has served as Medical Director in the country since July 2020 and will now take over the Latin America Medical Affairs Authority.

Finally, in 2023, Pfizer plans to introduce new treatments for migraine, atopic dermatitis, amyloidosis cardiomyopathy, and various cancers such as colorectal cancer, lung cancer, and melanoma.

Also read:

Pfizer’s vaccine made history by being the first to receive full FDA approval.

Cofepris makes it official: Pfizer’s vaccine is the only one approved for children in Mexico

GRAPH: This is the profit Pfizer will make in 2021 for its vaccine.

Source link

Leave a Comment